DURVAST: A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors

View all the projects

Project - Active

DURVAST: A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors

01/01/2017 – 31/12/2019

Principal Investigators: Javier Martínez-Picado
  • Participant entities: Spanish Lung Cancer Cooperative Group & IrsiCaixa AIDS Research Institute.
  • Funding entity: AstraZeneca

Subscribe to our newsletter

Back to Top
Irsi Caixa

Promoted by:

'La Caixa' Foundation Generalitat de Catalunya - Departament de Salut

 

HR Excellence in Research

Member of:

Cerca

In cooperation with: